FindTrial
Sign In

The value of new serum metabolites in the assessment of metabolic disorders in patients with heart failure

The value of new serum metabolites in the assessment of metabolic disorders in patients with heart failure and the mechanism

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17011240
Enrollment
Unknown
Registered
2017-04-25
Start date
2017-11-23
Completion date
Unknown
Last updated
2018-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure

Interventions

Case series:NA

Sponsors

Nanfang Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 years and older; 2. Patients hospitalized for heart failure; 3. Patients have signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with end-stage chronic diseases; 2. Patients with severe mental illness; 3. Patients can not understand the protocol or comply with the study; 4. Patients with malignant tumors.

Design outcomes

Primary

MeasureTime frame
TMAO;a-Ketoglutaric acid;PGC-1a;all-cause mortality;cardiovascular hospitalization;cardiovascular events;—

Countries

China

Contacts

Public ContactDingli XU

Nanfang Hospital, Southern Medical University

dinglixu@fimmu.com+86 13602720131

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 3, 2026